Scientific and grants management contacts by research area

Peer review contact:
Yujing Liu, MD, PhD
301.402.1366
liuyujin@mail.nih.gov

Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) will award funding to small business concerns (SBCs) to develop a product, process, or service with the aim of improving minority health and/or reducing and ultimately eliminating health disparities in one or more NIH-defined population groups.

The proposed technology should improve racial and ethnic minority health or reduce health disparities by addressing factors listed in the NIMHD Research Framework and/or by addressing other barriers and social determinants of health, including but not limited to:

• Physical barriers that may limit access to healthcare, such as transportation and proximity to facilities
• Knowledge barriers that can inhibit healthcare delivery, including health literacy and language barriers or lack of patient information for providers
• Infrastructure barriers for facilities such as rural health clinics, federally qualified health centers, and critical access hospitals that may not have the same resources and expertise of large hospitals and health networks
• Economic barriers that contribute to disparities in healthcare access, such as lack of financial resources or insurance coverage
• Cultural barriers that involve certain shared beliefs, social customs and practices that may impede access to or deter members of a social group from seeking care or engaging in health promoting activities or technologies

NIH-defined health disparity population groups include:

• Racial and ethnic minorities
• Socioeconomically disadvantaged individuals
• Individuals residing in rural areas
• Sexual and gender minorities

Appropriate technologies must be effective, affordable, culturally acceptable, and easily accessible to those who need them.

Specific areas of research interest are listed in the application instructions.

Small business concerns (SBCs) in the United States are eligible to apply.

Award ceiling: $259,613 for Phase I awards and $1,730,751 for Phase II awards
Project period: 1 year for Phase I and up to 2 years for Phase II
Estimated total program funding and number of awards: Based on research area and NIH Component

Links to the full announcement and the online application process are available through grants.gov.

Applicants are encouraged, but not required, to email a letter of intent to liuyujin@mail.nih.gov by March 5, 2022.